Consortium to investigate role of neurofilament light chain in neurodegenerative diseases (Links to an external site)

Consortium to investigate role of neurofilament light chain in neurodegenerative diseases
Clinical scientists at Washington University School of Medicine in St. Louis and University College London are collaborating with pharmaceutical companies AbbVie, Biogen, Bristol Myers Squibb and Roche to investigate the role of neurofilament light (NfL) chain in neurodegenerative diseases such as amyotrophic lateral sclerosis, Parkinson’s disease, Huntington’s disease and Alzheimer’s disease.

UCL Queen Square Institute of Neurology joins consortium to investigate neurodegenerative diseases (Links to an external site)

UCL Queen Square Institute of Neurology joins consortium to investigate neurodegenerative diseases
This collaborative effort between UCL, Washington University, and pharmaceutical companies such as AbbVie, Biogen, Bristol Myers Squibb and Roche aims to better understand the structure and role of NfL across different neurodegenerative diseases, including amyotrophic lateral sclerosis, Parkinson’s disease, Huntington’s disease and Alzheimer’s disease.

Are Aβ Blood Tests Ready for Prime Time? (Links to an external site)

Are Aβ Blood Tests Ready for Prime Time?
In the short space of two years, the erstwhile fantasy of a blood test for Alzheimer’s disease has become reality. Or so it seems. At the 2017 Alzheimer’s Association International Conference in London, Randall Bateman, Washington University, St. Louis, had wowed the audience by showing how an exquisitely sensitive mass spectroscopy assay of plasma detected a […]